Related Experiment Video
Updated: Dec 20, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China
Cong Ye1, Shaozhe Cai1, Guifen Shen1
1Department of Rheumatology and Immunology, Tongji Hospital of Tongji Medical College of Huazhong University of Science and Technology, Wuhan, China.
Insights
Rheumatic patients with coronavirus disease 2019 (COVID-19) had higher rates of respiratory failure. Differentiating COVID-19 from rheumatic disease flares is crucial for effective clinical management.
Area of Science:
- Rheumatology
- Infectious Diseases
- Internal Medicine
Background:
- Clinical features of coronavirus disease 2019 (COVID-19) in rheumatic patients remain largely unreported.
- Understanding these features is vital for clinical practice and patient management.
Purpose of the Study:
- To describe the clinical characteristics of COVID-19 in patients with rheumatic diseases.
- To provide insights for managing rheumatic patients during the COVID-19 pandemic.
Main Methods:
- A retrospective case series was conducted.
- Data from 2326 COVID-19 patients, including 21 with rheumatic disease, were analyzed.
Main Results:
- Rheumatic patients showed higher incidence of respiratory failure (38% vs. 10%) but similar hospital stay and mortality rates compared to non-rheumatic patients.
- Common symptoms included fever, fatigue, and diarrhea; four patients experienced rheumatic disease flares.
- Lymphocytopenia was frequent (57%) in rheumatic cases; hydroxychloroquine use was associated with non-critical illness.
Conclusions:
- Respiratory failure is a significant concern for rheumatic patients with COVID-19.
- Clinical differentiation between COVID-19 and rheumatic disease flares is essential.
Objective:
The clinical features of rheumatic patients with coronavirus disease 2019 (COVID-19) have not been reported. This study aimed to describe the clinical features of COVID-19 in rheumatic patients and provide information for handling this situation in clinical practice.
Methods:
This is a retrospective case series study. Deidentified data, including gender, age, laboratory and radiological results, symptoms, signs, and medication history, were collected from 2326 patients diagnosed with COVID-19, including 21 cases in combination with rheumatic disease, in Tongji Hospital between 13 January and 15 March 2020.
Results:
Length of hospital stay and mortality rate were similar between rheumatic and non-rheumatic groups, while the presence of respiratory failure was more common in rheumatic cases (38% vs 10%, p<0.001). Symptoms of fever, fatigue and diarrhoea were seen in 76%, 43% and 23% of patients, respectively. There were four rheumatic patients who experienced a flare of rheumatic disease during hospital stay, with symptoms of muscle aches, back pain, joint pain or rash. While lymphocytopaenia was seen in 57% of rheumatic patients, only one patient (5%) presented with leucopenia in rheumatic cases. Rheumatic patients presented with similar radiological features of ground-glass opacity and consolidation. Patients with pre-existing interstitial lung disease showed massive fibrous stripes and crazy-paving signs at an early stage. Five rheumatic cases used hydroxychloroquine before the diagnosis of COVID-19 and none progressed to critically ill stage.
Conclusions:
Respiratory failure was more common in rheumatic patients infected with COVID-19. Differential diagnosis between COVID-19 and a flare of rheumatic disease should be considered.
Trial Registration Number:
ChiCTR2000030795.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Endocarditis II: Clinical Features of Infective Endocarditis
Rheumatic Heart Disease I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Pericarditis II: Clinical Features and Diagnostic Tests
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

